Labial Bone Thickness Around Immediate Implants in the Esthetic Zone Following a Novel Socket Evaluation System

January 27, 2026 updated by: Ahmed Abo El Futtouh, Misr International University

a Novel Socket Evaluation System and Its Impact on Bone Formed Labial to Bone Immediate Anterior Implants. A 1-year Clinical Trial.

The anterior maxilla is a particularly challenging area for immediate implant placement due to its thin buccal bone walls. These walls are more susceptible to resorption after tooth extraction, which can lead to significant bone loss and inadequate support for an implant. However, Different socket dimension may affect the amount of bone formed labial to the implant, regardless of the garfting procedure.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Bone formation labial to the immediate implant is not related to the initial thick- ness of the labial plate of bone, rather than the initial labio-palatal socket dimension. this study aims to evaluate the bone formed labial to the implant following a Novel Socket Evaluation System.

Study Type

Observational

Enrollment (Estimated)

25

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
      • Cairo, Egypt
        • International Dental Clinic Educational centre
        • Contact:
        • Contact:
        • Principal Investigator:
          • Ahmed Aboul fettouh, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Primary care clinic

Description

Inclusion Criteria:

  • Immedaite implants in anterior maxilla
  • thick gingival phenotype
  • intact but thin labial plate of bone (≤1mm)
  • sufficient apical bone to attain implant primary stability (a minimum of 35 Ncm insertion torque)

Exclusion Criteria:

  • smokers
  • pregnant women
  • patients with systemic disease
  • patients with parafunctional habits such as bruxism or clenching,
  • infected socket
  • periapical pathosis
  • history of radiotherapy or chemotherapy within the past 2 years.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Bone grafts
Immediate implant placed with bone grafts in the labial gap
Procedure: Immediate implants with bone grafts
Immediate implants with bone grafts
No bone grafts
Immediate implant placed without bone grafts or any grafting substitutes in the labial gap
Procedure: Immediate implant placed without bone grafts or any grafting substitutes in the labial gap
Immediate implant placed without bone grafts or any grafting substitutes in the labial gap

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone labial to the implant
Time Frame: one year
measured at three levels 0, 2, and 5 mm below the labial bone crest after one year. Using fusion software.
one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone area at the Interproximal component
Time Frame: preoperative
Bone area at the mesial and distal Interproximal component in mm2
preoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Misr International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

October 16, 2024

First Submitted That Met QC Criteria

October 16, 2024

First Posted (Actual)

October 18, 2024

Study Record Updates

Last Update Posted (Actual)

January 28, 2026

Last Update Submitted That Met QC Criteria

January 27, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IDCE 14

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Immediate Implant Placement

Clinical Trials on Immediate implants with bone grafts

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe